Carbon Medical Technologies, Inc.

Carbon Medical Technologies, Inc. (formerly Advanced UroScience, Inc.) designs and manufactures implantable and minimally invasive medical devices using proprietary pyrolytic carbon coating technology. Founded in 1994, CMT is one of only five organizations worldwide with a dedicated pyrolytic carbon coating facility. The company specializes in devices for urological and oncological applications, with over 25 years of clinical use across 55+ countries and treatment of more than 1.4 million patients. CMT's primary product portfolio includes Durasphere® (an injectable bulking agent for stress urinary incontinence treatment), BiomarC® fiducial and tissue markers for radiation therapy and breast lesion localization, BiomarC® Restore for post-lumpectomy guidance, and the newly launched InjecSURE® cystoscopic injection system with female-specific anatomical design for urethral injections. The company operates under ISO 13485 and cGMP-compliant quality systems, maintains a validated ISO Class 7 cleanroom, and provides contract manufacturing services including design consultation, materials expertise, cleanroom assembly, and regulatory guidance. CMT supports multiple sterilization methods and manages the full product lifecycle from development through final delivery, positioning itself as a specialized provider for minimally invasive urology and oncology procedures.